These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11741979)

  • 1. Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase. Its functional implication in endothelial cell proliferation.
    Chang SY; Park SG; Kim S; Kang CY
    J Biol Chem; 2002 Mar; 277(10):8388-94. PubMed ID: 11741979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N terminus of pro-endothelial monocyte-activating polypeptide II (EMAP II) regulates its binding with the C terminus, arginyl-tRNA synthetase, and neurofilament light protein.
    Xu H; Malinin NL; Awasthi N; Schwarz RE; Schwarz MA
    J Biol Chem; 2015 Apr; 290(15):9753-66. PubMed ID: 25724651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate regulates the antiangiogenic activity of endothelial monocyte-activating polypeptide-II at acidic pH.
    Chang SY; Ko HJ; Heo TH; Kang CY
    Mol Pharmacol; 2005 May; 67(5):1534-43. PubMed ID: 15710745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II).
    Berger AC; Alexander HR; Wu PC; Tang G; Gnant MF; Mixon A; Turner ES; Libutti SK
    Cytokine; 2000 Jul; 12(7):992-1000. PubMed ID: 10880244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of CD23 as a functional receptor for the proinflammatory cytokine AIMP1/p43.
    Kwon HS; Park MC; Kim DG; Cho K; Park YW; Han JM; Kim S
    J Cell Sci; 2012 Oct; 125(Pt 19):4620-9. PubMed ID: 22767513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-surface associated p43/endothelial-monocyte-activating-polypeptide-II in hepatocellular carcinoma cells induces apoptosis in T-lymphocytes.
    Faisal W; Symonds P; Panjwani S; Heng Y; Murray JC
    Asian J Surg; 2007 Jan; 30(1):13-22. PubMed ID: 17337366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of p43(ARF), a derivative of the p43 component of multiaminoacyl-tRNA synthetase complex released during apoptosis.
    Shalak V; Guigou L; Kaminska M; Wautier MP; Wautier JL; Mirande M
    J Biol Chem; 2007 Apr; 282(15):10935-43. PubMed ID: 17303557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cytokine portion of p43 occupies a central position within the eukaryotic multisynthetase complex.
    Norcum MT; Warrington JA
    J Biol Chem; 2000 Jun; 275(24):17921-4. PubMed ID: 10787402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel anti-tumor cytokine contains an RNA binding motif present in aminoacyl-tRNA synthetases.
    Kim Y; Shin J; Li R; Cheong C; Kim K; Kim S
    J Biol Chem; 2000 Sep; 275(35):27062-8. PubMed ID: 10852899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II-dependent mechanism.
    Murray JC; Symonds P; Ward W; Huggins M; Tiga A; Rice K; Heng YM; Todd I; Robins RA
    J Immunol; 2004 Jan; 172(1):274-81. PubMed ID: 14688335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p43 component of the mammalian multi-synthetase complex is likely to be the precursor of the endothelial monocyte-activating polypeptide II cytokine.
    Quevillon S; Agou F; Robinson JC; Mirande M
    J Biol Chem; 1997 Dec; 272(51):32573-9. PubMed ID: 9405472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (1)H, (13)C, and (15)N chemical shifts assignments for human endothelial monocyte-activating polypeptide EMAP II.
    Lozhko D; Stanek J; Kazimierczuk K; Zawadzka-Kazimierczuk A; Kozminski W; Zhukov I; Kornelyuk A
    Biomol NMR Assign; 2013 Apr; 7(1):25-9. PubMed ID: 22392337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A peptide derived from the amino terminus of endothelial-monocyte-activating polypeptide II modulates mononuclear and polymorphonuclear leukocyte functions, defines an apparently novel cellular interaction site, and induces an acute inflammatory response.
    Kao J; Fan YG; Haehnel I; Brett J; Greenberg S; Clauss M; Kayton M; Houck K; Kisiel W; Seljelid R
    J Biol Chem; 1994 Apr; 269(13):9774-82. PubMed ID: 7545917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ATP synthase alpha subunit in low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
    Li Z; Liu YH; Xue YX; Xie H; Liu LB
    J Neurol Sci; 2011 Jan; 300(1-2):52-8. PubMed ID: 21035144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of AIMP1/p43 and EMAP II recombinant proteins in the complexes with polysaccharide dextran-70.
    Kolomiiets LA; Vorobyova NV; Lozhko DM; Zayets VM; Kornelyuk AI
    Pharmacol Rep; 2020 Feb; 72(1):238-245. PubMed ID: 32016851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial monocyte-activating polypeptide-II and its functions in (patho)physiological processes.
    van Horssen R; Eggermont AM; ten Hagen TL
    Cytokine Growth Factor Rev; 2006 Oct; 17(5):339-48. PubMed ID: 16945568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of EMAP II in the developing and adult mouse.
    Knies UE; Kröger S; Clauss M
    Apoptosis; 2000 Apr; 5(2):141-51. PubMed ID: 11232242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of EMAP II by hypoxia.
    Matschurat S; Knies UE; Person V; Fink L; Stoelcker B; Ebenebe C; Behrensdorf HA; Schaper J; Clauss M
    Am J Pathol; 2003 Jan; 162(1):93-103. PubMed ID: 12507893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.
    Berger AC; Alexander HR; Tang G; Wu PS; Hewitt SM; Turner E; Kruger E; Figg WD; Grove A; Kohn E; Stern D; Libutti SK
    Microvasc Res; 2000 Jul; 60(1):70-80. PubMed ID: 10873516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent biphasic activity of tRNA synthetase-associating factor, p43, in angiogenesis.
    Park SG; Kang YS; Ahn YH; Lee SH; Kim KR; Kim KW; Koh GY; Ko YG; Kim S
    J Biol Chem; 2002 Nov; 277(47):45243-8. PubMed ID: 12237313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.